Table 2.
Drug | Model of study | ROS/antioxidant | Cell death type | Ref. |
---|---|---|---|---|
Methylprednisolone | Thymocytes0 | Peroxides and decreased GSH | Apoptosis | [71] |
Artesunate | Doxorubicin-resistant T leukemia cells | Hydrogen peroxide | Intrinsic apoptosis | [65] |
Vibrio vulnificus cytolysin | Vascular endothelial ECV304 cells | Superoxide anion | Intrinsic apoptosis | [66] |
Angiotensin II | Myocardial ischemia | Superoxide anion and/or hydrogen peroxide | Intrinsic apoptosis | [69] |
TNF-α | Mesangial cells | Superoxide anion | Extrinsic apoptosis | [65] |
Matrine | Liver HL-7702 cells | Hydrogen peroxide and lipid peroxidation Decreased SOD and GSH activity, KEAP1 upregulation, Nrf2 downregulation and inhibition of HO-1 and NQO1 |
Intrinsic and extrinsic apoptosis | [64] |
Oxidized perilla and linseed oil | Neuronal SH-SY5Y cells | Hydrogen peroxide | Caspase-independent apoptosis (AIF) and intrinsic apoptosis | [74] |
Clemastine and ibrutinib combination | CLL cells | Superoxide anion and/or hydrogen peroxide | Apoptosis | [72] |
Sodium selenite | Prostate cancer PC3 | Superoxide anion | Apoptosis | [115] |
Glucose-decorated selenium nanoparticles | Hepatocellular carcinoma HepG2 cells | Superoxide anion and/or hydrogen peroxide | Apoptosis | [122] |
BAY 87-2243 | Hepatoma cell line Hep3B | ROS | Apoptosis | [137] |
Siramesine and lapatinib combination | Breast cancer MDA MB 231cells, adenocarcinoma A549 cells, and glioblastoma U87 cells | Iron-mediated ROS and lipid peroxidation | Ferroptosis | [120, 121] |
Paraquat and maneb | Neuronal SH-SY5Y cells | Lipid peroxidation NADPH-mediated ROS Decreased GSH and GPx4 |
Ferroptosis | [86] |
Hemin | Monocytic THP-1 cells | Iron-mediated ROS and NADPH-mediated ROS | Ferroptosis | [85] |
Artesunate | Hepatic stellate LX2 cells | Iron mediate ROS and lipid peroxidation Decreased GSH and GPx4 activity |
Ferroptosis | [87] |
Deletion of Acsl4 and RSL3 | Acute kidney failure | Oxidation of fatty acids | Ferroptosis | [132] |
Deletion of Acsl4 and TNF-α and zVAD-fmk | Acute kidney failure | Oxidation of fatty acids | Necroptosis | [132] |
Rotenone | HEK 293, U87, and HeLa cells | Superoxide anion and/or hydrogen peroxide | Autophagic cell death | [99] |
Bufaline | Colon cancer HT-29 and Caco-2 cells | Hydrogen peroxide | Autophagic cell death | [100] |
Amyloid-β1-42 | Glioblastoma U87 and SH-SY5Y cells | Hydrogen peroxide | Autophagic cell death | [101] |
β-Lapachone | Glioblastoma U87 cells | Hydrogen peroxide | Autophagic cell death | [102] |
Selenium nanoparticles | Prostate cancer PC3 cells | Superoxide anion and/or hydrogen peroxide | Necroptosis | [114] |
Alkynyl gold(I) complex | Colorectal adenocarcinoma Caco-2 cells | ROS | Necroptosis | [116] |
TNF-α | Mouse embryonic fibroblast RelA KO and cIAP1/2 DKO cells | Hydrogen peroxide | Necroptosis | [117] |
FTY720 | U87 and U251MG xenograft mouse model | ROS | Autophagy and ferroptosis and necroptosis | [118] |
BAY 87-2243 | BRAF mutant melanoma mouse xenografts and patient-derived melanoma mouse models | ROS and lipid peroxidation | Ferroptosis and necroptosis | [135] |